1."Outside-in" Arthroscopic Cam Resection in the Treatment of Femoroacetabular Impingement Syndrome
Haitao XU ; Weihong ZHU ; Bin CAO ; Zhiyong CHAI ; Jianfeng TANG ; Zizhen SHU
Chinese Journal of Sports Medicine 2018;37(5):373-376
Objective To evaluate the efficacy and safety of "outside-in" arthroscopic cam resection in the treatment of femoroacetabular impingement (FAI)syndrome.Methods Nine patients were treated with "outside-in" hip arthroscopy for cam or mixed type FAI syndrome between July 2015 and July 2016.All the 9 patients(11 hips)underwent osseous correction of the femoral neck and labral debridement.Before the surgery and 12 months after it,all patients were evaluated using the Harris Score and their complications were observed.Results The average postoperative Harris Score(92.5,range from 64 to 100)was significantly better compared with the preoperative one(56.4,range from 22 to 70,P< 0.001).One patient with blister on dorsal foot and another with fluid leakage were cured.No neurovascular injuries or cartilage injuries were found among all the patients.Conclusion "Outside-in" arthroscopic treatment of FAI with osseous correction and labral debridement is safe and effective.
2.Short-term efficacy of laparoscopic total gastrectomy with hand-sewn esophagojejunostomy versus Roux-en-Y anastomosis using propensity score matching
Xinli MA ; Yihuang WANG ; Jiayi GU ; Linxi YANG ; Jia XU ; Zizhen ZHANG ; Hui CAO ; Jiangfeng QIU
Chinese Journal of Digestive Surgery 2022;21(5):628-634
Objective:To investigate the short-term efficacy of laparoscopic total gastrec-tomy with hand-sewn esophagojejunostomy versus Roux-en-Y anastomosis.Methods:The propen-sity score matching and retrospective cohort study was conducted. The clinicopathological data of 159 patients who underwent laparoscopic total gastrectomy in Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine from October 2014 to July 2021 were collected. There were 107 males and 52 females, aged 63(range, 28?79)years. Of 159 patients, 71 cases undergoing totally laparoscopic total gastrectomy with hand-sewn esophagojejunostomy were allocated into totally laparoscopic group and 88 cases undergoing laparoscopic-assisted total gastrectomy with Roux-en-Y anastomosis were allocated into laparoscopic-assisted group, respectively. Observation indicators: (1) propensity score matching and comparison of general data of patients between the two groups after matching; (2) intraoperative and postoperative conditions; (3) perioperative complications. Propensity score matching was done by the 1:1 nearest neighbor matching method. Measurement data with normal distribution were expressed as Mean± SD, and t test was used for comparison between groups. Measurement data with skewed distribution were expressed as M(range), and the Mann-Whitney U test was used for comparison between groups. Count data were expressed as absolute numbers or percentages, and comparison between groups was analyzed using the chi-square test or Fisher's exact probability method. The rank sum test was used for comparison of ordinal data. Results:(1) Propensity score matching and comparison of general data of patients between the two groups after matching. Of 159 patients, 112 cases were successfully matched, including 56 cases in the totally laparoscopic group and 56 cases in the laparoscopic-assisted group. Before propensity score matching, age, cases with tumor located in cardia or gastric body in the totally laparoscopic group were 61(range, 30?76)years, 26, 45, respectively. The above indicators in the laparoscopic-assisted group were 65(range, 28?79)years, 50, 38, respectively. There were significant differences in the above indicators between the two groups ( Z=?2.89, χ2=6.43, P<0.05). After propensity score matching, the males and females, age, body mass index, cases of American Society of Anesthesiologists classification Ⅰ, Ⅱ, Ⅲ and Ⅳ, tumor diameter, cases with tumor located in cardia or gastric body, cases in TNM stage Ⅰ, Ⅱ and Ⅲ of patients in the totally laparoscopic group were 40, 16, (62±9)years, (22.7±2.8)kg/m 2, 22, 26, 7, 1, 3.5(range, 0.6?17.0)cm, 24, 32, 22, 9, 25. The above indicators of patients in the laparoscopic-assisted group were 38, 18, (62±10)years, (22.7±3.2)kg/m 2, 19, 32, 5, 0, 4.0(range, 0.6?15.0)cm, 23, 33, 21, 7, 28, respectively. There was no significant difference in the above indicators between the two groups ( χ2=0.17, t=?0.09, ?0.04, Z=?0.12, ?0.82, χ2=0.04, Z=?0.42, P>0.05). The elimination of age and tumor location confounding bias ensured comparability between the two groups. (2) Intraoperative and postoperative conditions: after propensity score matching, the total operation time, time of esophagojejunostomy, postopera-tive 24-hour pain numerical score and time to first out-off bed activities were (310±49)minutes, (37±10)minutes, 2.3±0.8 and (2.4±0.7)days for patients in the totally laparoscopic group, versus (344±77)minutes, (44±12)minutes, 3.1±1.2 and (2.9±1.0)days in the laparoscopic-assisted group, showing significant differences between the two groups ( t=?2.85, ?3.05, ?4.20, ?3.10, P<0.05). (3) Perioperative complications: after propensity score matching, 6 cases of the patients in the totally laparoscopic group had Clavien-Dindo grade 2 or higher complications, including 2 cases of anas-tomotic leak, 1 case of anastomotic stenosis, 1 case of pleural effusion, 1 case of abdominal infection and 1 case of intestinal obstruction. The incidence of Clavien-Dindo grade 2 or higher complications was 10.7%(6/56). In the laparoscopic-assisted group, 5 patients had Clavien-Dindo grade 2 or higher complications, including 2 cases of anastomotic leak, 1 case of abdominal infection, 1 case of intestinal obstruction and 1 case of cholangitis. The incidence of Clavien-Dindo grade 2 or higher complications was 8.9%(5/56). There was no significant difference in the incidence of Clavien-Dindo grade 2 or higher complications between the two groups ( χ2=0.10, P>0.05). Patients with anas-tomotic leak were improved after puncture and drainage, secondary surgery and conservative treat-ment, and other complications were improved after symptomatic treatment. Conclusions:Com-pared with Roux-en-Y anastomosis in laparoscopic total gastrectomy, the time of hand-sewn esophagojejunostomy and esophago-jejunal anastomosis are shorter, patients have less postopera-tive pain and faster postoperative recovery. Both methods have good peri-operative safety.
3.Progress in application of peritoneal lavage fluid circulating tumor DNA to predicting peritoneal metastasis of gastrointestinal cancer
Long BAI ; Xiang XIA ; Hui CAO ; Zizhen ZHANG
Journal of Shanghai Jiaotong University(Medical Science) 2023;43(12):1554-1561
Peritoneal metastasis is one of the important causes of death in patients with gastrointestinal cancer and is also a difficult point in clinical diagnosis and treatment.How to predict the occurrence of peritoneal metastasis in patients with high-risk factors,advance the threshold of diagnosis and treatment before the occurrence of peritoneal metastasis,and improve the survival benefit of patients is an unsolved problem in clinical work.In the case of low positive rate of cytology and difficulty in diagnosing occult peritoneal metastasis,new molecular markers and detection techniques for early diagnosis of peritoneal metastasis need to be verified.Peritoneal lavage fluid has the characteristics of less leukocyte-derived cell-free DNA interference,higher concentration of circulating tumor DNA(ctDNA),and direct contact with the primary lesion or potential peritoneal metastasis at physical distance,making it a unique advantage in gastrointestinal cancer.At present,the detection methods of ctDNA in peritoneal lavage fluid include digital PCR,epigenetic-based analysis,and next-generation sequencing.With the iteration of technology,the application of next-generation sequencing and personalized panels to ctDNA detection has not only shown great potential in predicting postoperative peritoneal metastasis,but also promoted the idea of preventive escalation treatment of peritoneal metastasis.This article reviews the current application of ctDNA to peritoneal lavage fluid in predicting peritoneal metastasis of gastrointestinal cancer.
4.Lentiviral vector-mediated RNA interference of mouse epididymis-specific meClps gene lowers mouse sperm mobility.
Zizhen LIAN ; Zuowu CAO ; Ran CHEN ; Lei CHEN ; Yingzi XUE ; Junwen QIN ; Xufeng QI ; Chunxue ZHANG ; Yanhong YU
Journal of Southern Medical University 2014;34(9):1359-1364
OBJECTIVETo analyze the effect of small interfering RNA (siRNA) targeting mouse epididymis-specific colipase-like (meClps) gene on mouse sperm mobility.
METHODSThe eukaryotic expression vector pDsRed2.0-C1-meClps was constructed and transfected into NIH-3T3 cells, and the protein expression was detected with anti-meClps serum. Three interfering sequences targeting meClps (RNAi-251, 224 and 286) were inserted into lentiviral vectors pRNAT-U6.2/lenti, which were co-transfected with pDsRed2.0-C1-meClps into NIH-3T3 cells. The RNA interfering efficiency was confirmed by semi-quantitative PCR and Western blotting. The lentivirus, packed with the lentiviral vector with the highest interfering efficiency, was injected into the caput tissues of mouse epididymis, and its effect on sperm mobility of the cauda epididymis was evaluated.
RESULTSAll the 3 lentiviral RNAi vectors targeting meClps could inhibit the mRNA and protein expressions of meClps, among which pRNAT-U6.2/lenti-RNAi-251 had the highest interfering efficiency. The lentivirus packed with pRNAT-U6.2/lenti-RNAi-251 significantly reduced the path velocity of cauda sperm after injection into the caput epididymis of the mice (P<0.05).
CONCLUSIONKnock-down meClps expression by lentiviral-mediated RNA interference can lower sperm mobility of mice.
Animals ; Epididymis ; Gene Targeting ; Genetic Vectors ; Lentivirus ; Male ; Mice ; NIH 3T3 Cells ; RNA Interference ; RNA, Messenger ; RNA, Small Interfering ; Sperm Motility ; Spermatozoa ; Transfection
5.Effects and mechanism of veratramine on the proliferation of human glioblastoma U251 cells
Zizhen CAO ; Lin ZHANG ; Ruoqiu FU ; Yibo ZHAO ; Xiang CHEN ; Jianhong CHEN
China Pharmacy 2023;34(22):2734-2739
OBJECTIVE To explore the effects and potential mechanism of veratramine (VTM) on the proliferation of human glioblastoma U251 cells. METHODS The network pharmacology methods were adopted to screen the targets of ferroptosis related to the effects of VTM on glioblastoma, and to conduct gene ontology and Kyoto Encyclopedia of Genes and Genosomes enrichment analysis. Using U251 cells as the object, CCK-8 assay, the observation of cell morphological changes, DCFH-DA fluorescence probe method, FerroOrange fluorescence probe method and Western blot assay were used to validate the inhibitory effects of VTM on U251 cell proliferation and its possible mechanism. RESULTS Totally 462 targets of ferroptosis related to the effects of VTM on glioblastoma were screened out; they mainly enriched in biological processes such as oxidative stress and apoptosis, and cellular components such as cytoplasmic vesicles and mitochondrial membranes; they affected molecular functions such as iron ion (Fe2+) binding and DNA transcription processes, as well as iron death and phosphoinositide 3-kinase/protein kinase B signaling pathways. VTM with 40, 60, 80, 100, 120 and 140 μmol/L could significantly reduce the cell survival rate (P< 0.01); VTM with 40, 80 and 120 μmol/L could cause cell atrophy and nuclear fragmentation, significantly inhibit the clone formation, increase the levels of intracellular reactive oxygen species (ROS) and Fe2+ levels, increase the expressions of nuclear factor-erythroid 2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1) protein to different extents, while down-regulate the expression of glutathione peroxidase 4 (GPX4) protein (P<0.05 or P<0.01). CONCLUSIONS VTM can inhibit the proliferation of U251 cells, and promote the accumulation of intracellular ROS and Fe2+, thus inducing ferroptosis; its mechanism might be related to the regulation of the Nrf2/HO-1/GPX4 signaling pathway.